openPR Logo
Press release

Specialty Pharmaceuticals Market To Cut Through Linear Growth

08-11-2022 07:37 AM CET | Health & Medicine

Press release from: Persistence Market Research

Specialty Pharmaceuticals Market To Cut Through Linear Growth

The Specialty Pharmaceuticals Market is expected to grow at an unstoppable rate In Upcoming Years. With environmental health being a matter of concern, everything - right from public transport networks, power supply, and storage of waste to monitoring the ecological balance is being taken up by IoT and AI. It could, thus, be inferred that with "smart cities" would come "smart end-user solutions" in the years to come.

Drug molecules that help in treating specific genetic conditions which don't have any therapeutic intervention in the market are considered to be as specialty pharmaceuticals. Specialty Pharmaceuticals are more targeted drugs and have less toxic in nature when compared with traditional drugs.

Specialty pharmaceuticals include biopharmaceuticals, blood derived products and complex molecules. Pharmaceuticals that are having high cost also falls under the specialty pharmaceuticals. The cost of specialty pharmaceuticals threshold is around $600 per month.

The average cost for specialty medical therapy is around $35,000 to $75,000 costs per patient per year. Specialty pharmaceuticals are mainly available at physician offices in another way these are mostly available through prescriptions. Specialty pharmaceuticals are having the fastest growth in the U.S.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/12820

According to a research study, specialty pharmaceuticals drug spending increased in the US by 26.5% in 2014 this is due to the recent launch of drugs for hepatitis C. Specialty pharmaceuticals are gaining traction in the pharma industry is due to lack of proper interventions for few disease conditions and faster regulatory approvals are driving the growth of this market.

In 2014, around 27 specialty pharmaceuticals got U.S regulatory approvals when compared with 24 traditional drug approvals. Companies are also actively involved in developing specialty pharmaceuticals on rare disease conditions to get orphan drug status for their drugs.

In 2015, Europe regulatory authorities approved more medicines for rare diseases around 93 newly approved medicines, and 18 are orphan drugs. Hence, companies are mainly focusing these specialty pharmaceutical owing to their higher revenues and high-profit margins.

For instance, in FY 2014, Teva overall revenue was around $ 20 billion out of that 42% of sales revenue was contributed by the specialty pharmaceutical drugs. Among the specialty pharmaceuticals drugs, Copaxone generated around 50% of the sales revenue.

Request for Table of Content@ https://www.persistencemarketresearch.com/toc/12820

Based on therapeutic area

• Oncology
• Inflammatory conditions
• Multiple sclerosis
• Growth hormone
• Other disease conditions
Based on route of administration • Oral
• Parenteral
• Transdermal
Based on distribution channel • Hospitals
• Retail Pharmacies
• Specialty Pharmacies
• Mail Order

Based on therapeutic area, specialty pharmaceuticals market is segmented into oncology, inflammatory conditions, multiple sclerosis and other disease indications. Among them, oncology occupies the major market share followed by inflammatory conditions.

According to WHO, cancers are the leading cause of mortality and morbidity worldwide with an incidence of 14 million cancer cases and 8.2 million cancer-related deaths. In inflammatory disease condition, rheumatoid arthritis occupies the significant market share for the specialty pharmaceuticals when compared with other inflammatory disease conditions.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/12820

The higher cost of the drugs is hindering the growth of the specialty pharmaceuticals market. Based on the route of administration, the specialty pharmaceuticals market is segmented into oral, parenteral and transdermal. Parenteral route occupies the major market share followed by the oral route.

On the basis of the distribution channel, specialty pharmaceuticals market is segmented into hospitals, retail, specialty pharmacies and mail order. Hospitals occupy the major pie in the specialty pharmaceutical products this is mainly due to the availability of these drugs over prescription.

Other than hospitals, retail pharmacies, and specialty pharmacies are also have good market share during the forecast period. However, during the forecast period, specialty pharmacies are expected to occupy the major market share when compared with retail pharmacies over the forecast period.

Based on geography, specialty pharmaceuticals market is segmented into five key regions: North America, Latin America, Europe, Asia-Pacific and the Middle East & Africa. North America accounts the significant market share due to high buying power and reimbursement for the specialty pharmaceuticals are the major factors boosting the growth of this market during the forecast period. Asia Pacific specialty pharmaceuticals market is expected to grow over the forecast period owing to the growth of biopharmaceutical industry in China and India.

Major players in the specialty pharmaceuticals market include Teva Pharmaceuticals, Abbvie Inc, Amgen, Johnson & Johnson, Celgene, Gilead Sciences, Roche are the key players in the market. Top 10 U.S specialty pharmaceuticals itself generated around $ 37B revenue in 2012. In U.S specialty pharmaceuticals, Humira is one of the top-selling specialty pharmaceutical drug and it accounted $4.4B in 2012 and expected to dominate the market till 2018.

Contact Us:
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com

About us:
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Specialty Pharmaceuticals Market To Cut Through Linear Growth here

News-ID: 2702975 • Views: 200

More Releases from Persistence Market Research

Wound Antiseptics Market Growth to Surge Owing to Increasing Adoption by End-use …
The global Wound Antiseptics Market is all set to witness a CAGR of 3.5% by the year 2032. With digitized communication channels making a beeline to the healthcare vertical, the advanced clinics are into virtual consultation mode, and this scenario is expected to continue even going forward. Regulatory approvals for this type of communication are on the way. Close to 70% of the public hospitals worldwide are being asked to
The Next Decade See Lentiviral Vectors Market Pushed Towards Exponential Advance …
The Lentiviral Vectors Market is slated to grow at a gracious rate of 11.4% by the year 2032. With value-oriented approach being the need of the hour, the healthcare vertical is likely to go the technologically advanced way in the next 10 years. With Big Data, AI comprising these advancements, the healthcare vertical is bound to create greater strides going forward. Lentiviral vectors are gene delivery mechanisms that are produced from
Global Cognitive Decline Market to Exhibit Increased Demand in the Coming Years
Owing to rising demand for non-invasive brain stimulation, the global cognitive decline market was valued at over US$ 2 Bn in 2020, and is expected to exhibit a CAGR of 5.8 % over the forecast period (2021-2031). Cognitive decline is a condition in which the brain does not work as well as it should. According to the Centers of Disease Control and Prevention (CDC) report, the prevalence of cognitive decline in
Demand for Glycan Analysis Market Driven by Shifting Consumer Perceptions and Gr …
Introduction Therapeutic monoclonal antibodies (mAbs) are glycoproteins produced by living cell systems and the process is known as protein glycosylation. The glycan moieties attached to the proteins directly affects in-vivo bioactivity, stability, solubility and metabolic activity of bio therapeutics or biopharmaceutical products. Glycosylation is a post-translational modification and, is a non-template driven enzymatic modification process. Its structure largely depends up on production methods and conditions. Due to this reason the product can

All 5 Releases


More Releases for Specialty

Global Specialty Zeolites Market, Global Specialty Zeolites Industry, Covid-19 I …
The Specialty Zeolites market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The Global Specialty Zeolites Market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Specialty Zeolites market. The report focuses on well-known providers in the global
Global Specialty Wire Sales Market 2018:2025 - MWS Wire, Torpedo Specialty Wire, …
The Specialty Wire Sales market research report is a comprehensive emphasizing study of the industry The Global Specialty Wire Sales market 2018-2025 report offers a extensive and precise estimates and forecasts study of Specialty Wire Sales industry along with the analysis of essential features providing key industry insights to the readers. The Specialty Wire Sales market research report further delivers an methodical outlook of the industry by studying key components impacting
Global Specialty Wire Market Size and Growth Analysis (2019 - 2025) by Top Key P …
Global specialty wire market report is first of its kind research report that covers the overview, summary, market dynamics, competitive analysis, and leading player’s various strategies to sustain in the global market. The specialty wire report covers the five top regions of the globe and countries within, which shows the status of regional development, consisting of market value, volume, size, and price data.  Apart from this, the specialty wire report
Specialty Wire Market 2018-2025 Key Players: MWS Wire, Torpedo Specialty Wire, S …
Specialty Wire Market Summary:Reports Monitor has added new report titled, ‘Global Specialty Wire Market Review 2017-2018 Forecast to 2025 - Analysis by Chemical Type, Technology, Application, End-User, Industry Vertical, and Region’ into its vast depository of research reports. In the first section of the report, the market definition, market overview, product description, product scope, product characterization, and product specification has been discussed. The information presented in this report provides an overview of the
Specialty Surfactants Market
Latest Developments Growing personal care industry in emerging economies and increasing purchasing power of middle class are fuelling the growth of the specialty surfactants market. While stringent environmental regulations regarding the manufacturing of specialty surfactants are hindering the growth of this market. Market Insights Anionic surfactants is poised to account for the largest market share in 2016 and owing to the increased use of green surfactants amphoteric surfactants have registered the highest CAGR.
Specialty Wire 2017 Global Market Key Players – MWS Wire, Torpedo Specialty Wi …
Specialty Wire SWOT Analysis And Forecast 2022 This report studies Specialty Wire in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering MWS Wire Torpedo Specialty Wire Specialty Wire and Cable (SWC) LANOCO Specialty